[Possibility of improvement of cerebral function under the effect of prolonged combined infusions-injections oral therapy in geriatrics].
D000284:Administration, Oral; D000368:Aged; D001288:Attention / Q000187:drug effects; D001549:Benzamides / Q000008:administration & dosage; D001565:Benzoates / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects; D002396:Catechols / Q000008:administration & dosage*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage*; D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy*; D003119:Color Perception Tests; D003864:Depression, Chemical; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000150:complications; D004644:Emotions / Q000187:drug effects; D004678:Encephalomalacia / Q000150:complications / Q000188:drug therapy*; D005029:Ethylenediamines / Q000008:administration & dosage; D005260:Female; D006261:Headache / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D008297:Male; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D013806:Theophylline / Q000008:administration & dosage; D014665:Vasodilator Agents / Q000008:administration & dosage*; D014717:Vertigo / Q000188:drug therapy
D001549:Benzamides; D001565:Benzoates; D002396:Catechols; D000697:Central Nervous System Stimulants; D005029:Ethylenediamines; D014665:Vasodilator Agents; D013806:Theophylline
Beobachtungen über die Möglichkeit der zerebralen Funktionsverbesserung in der Geriatrie unter einer kombinierten Infusions-Injektions-Langzeit-Oraltherapie.